SCHEMBL6157860

SCHEMBL6157860

COC(=O)c1c(N)sc(-c2ccc(Cl)cc2)c1C

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 6/20 0.75
MDM2 Q00987 6/20 0.75
GRM6 O15303 8/20 0.74
GRM5 P41594 1/20 0.74
ALDH1A1 P00352 3/20 0.56
MAPT P10636 3/20 0.56
KDM4E B2RXH2 2/20 0.56
GAA P10253 2/20 0.56
HPGD P15428 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
PKM P14618 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
NPC1 O15118 1/20 0.50
CASP3 P42574 1/20 0.50
RAB9A P51151 1/20 0.50
SENP8 Q96LD8 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50
MEN1 O00255 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6159255 0.87 GRM6 (0.78) TP53MDM2GRM6GRM5ALDH1A1
SCHEMBL25758961 0.86 GRM6 (0.76) TP53MDM2GRM6GRM5ALDH1A1
SCHEMBL10714368 0.85 GRM6 (1.00) TP53MDM2GRM6GRM5ALDH1A1
SCHEMBL10489596 0.85 GRM6 (0.76) TP53MDM2GRM6GRM5ALDH1A1
SCHEMBL4095490 0.84 TP53 (0.56) TP53MDM2GRM6GRM5ALDH1A1
SCHEMBL6613252 0.78 TP53 (0.53) TP53MDM2GRM6GRM5ALDH1A1
SCHEMBL18955924 0.75 TP53 (0.60) TP53MDM2GRM6GRM5ALDH1A1
SCHEMBL6160814 0.75 GRM6 (1.00) TP53GRM6GRM5ALDH1A1MAPT
SCHEMBL12483139 0.74 KDM4E (0.50) TP53MDM2GRM6GRM5ALDH1A1
SCHEMBL6161028 0.74 GRM6 (0.70) TP53MDM2GRM6GRM5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6849738-B2 Processes for the production of thienopyrimidine derivatives TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-02-01 US disclosed
US-20030055269-A1 Processes for the production of thienopyrimidine derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-03-20 US disclosed
EP-1266898-A1 PROCESSES FOR THE PRODUCTION OF THIENOPYRIMIDINE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2002-12-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055269-A1 Processes for the production of thienopyrimidine derivatives GNRHR, NR5A1, DHODH TP53 2093/4885MDM2 2095/4885GRM6 136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.